Pregnancy outcome following maternal exposure to pregabalin may call for concern.

• Winterfeld U From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. ursula.winterfeld@chuv.ch.
• Merlob P From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Baud D From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Rousson V From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Panchaud A From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Rothuizen LE From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Bernard N From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Vial T From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Yates LM From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Pistelli A From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Ellfolk M From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Eleftheriou G From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• de Vries LC From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Jonville-Bera AP From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Kadioglu M From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Biollaz J From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
• Buclin T From STIS (Swiss Teratogen Information Service) and Division of Clinical Pharmacology (U.W., A.P., L.E.R., J.B., T.B.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; BELTIS Rabin Medical Center and Sackler School of Medicine (P.M.), University of Tel-Aviv, Israel; Materno-Fetal and Obstetrics Research Unit (D.B.) and Institute of Social and Preventive Medicine (IUMSP) (V.R.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre Régional de Pharmacovigilance (N.B., T.V.), Hospices Civils de Lyon, France; UKTIS (L.M.Y.), Regional Drug and Therapeutics Centre, Newcastle upon Tyne Hospitals NHS Trust, UK; Centro di Riferimento Regionale di Tossicologia Perinatale (A.P.), Azienda Ospedaliero Universitaria Careggi, Florence, Italy; HUCH Teratology Information Service (M.E.), HUCH Emergency Care, Helsinki, Finland; Poison Control (G.E.), Bergamo, Italy; TIS (L.C.d.V.), Netherlands Pharmacovigilance Centre Lareb, Den Bosch; Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, the Netherlands; Centre de Pharmacovigilance de Tours (A.-P.J.-B.), CHRU, Tours, France; and Department of Pharmacology (M.K.), Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.

Show more…

Abnormalities, Drug-Induced

Adult

Central Nervous System Agents

Europe

Female

Humans

Incidence

Pharmacovigilance

Pregabalin

Pregnancy

Pregnancy Outcome

Pregnancy Trimester, First

Proportional Hazards Models

Prospective Studies

Risk